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The protein kinase PKB/Akt has long been associated with regulating signaling pathways that promote 
cell survival and cell growth, for example, in response to growth factors. In contrast, the DNA-dependent 
protein kinase (DNA-PK) is required for the repair of DNA damage and for cell survival after exposure to 
DNA-damaging agents, such as ionizing radiation. In a recent paper published in Molecular Cell, Hemmings 
and colleagues provide evidence that DNA-PK is required for the activation of PKB in response to exposure 
to ionizing radiation, suggesting that these two protein kinases may act together to promote survival after 
DNA damage.Protein kinase B (PKB) (also called AKT) 
is a classical serine/threonine protein 
kinase that plays a critical role in cell sig-
naling in eukaryotes (reviewed in Man-
ning and Cantley, 2007). The classical 
PKB signaling pathway involves growth 
factor-dependent activation of class 1A 
phosphoinositide 3 kinase (PI3K), phos-
phorylation of plasma membrane-bound 
phosphatidylinositol 4,5 bis-phosphate 
(PIP2) to phosphatidylinositol 3,4,5 tris-
phosphate (PIP3), and PIP-dependent 
activation of phosphoinositide kinase-1 
(PDK1), which phosphorylates PKB 
on threonine 308 in the protein kinase 
activation loop. Also required for PKB 
activation is phosphorylation on serine 
473 by a kinase or kinases referred to as 
PDK2. The most well-described PDK2 
is mTORC2, a complex composed of the 
PI3K-like protein kinase (PIKK) mTOR, 
with Rictor and other proteins, which 
phosphorylates PKB on serine 473 in 
response to activation by growth fac-
tors (Manning and Cantley, 2007). How-
ever, other protein kinases have also 
been shown to phosphorylate PKB on 
serine 473, including other PIKK family 
members, DNA-PKcs (Feng et al., 2004) 
and ATM (Viniegra et al., 2005).
DNA-PKcs (the catalytic subunit of 
the DNA-dependent protein kinase) is 
required for the repair of ionizing radia-
tion (IR)-induced DNA damage via the 
nonhomologous end-joining pathway 
(NHEJ). The first step in NHEJ is recog-
nition of IR-induced DNA double-strand 
breaks (DSBs) by the Ku heterodimer, followed by recruitment of DNA-PKcs, 
and stimulation of its kinase activity. The 
protein kinase activity of DNA-PKcs is 
required for NHEJ, but to date its physi-
ological targets have remained elusive 
(Weterings and Chen, 2007).
In a recent paper in Molecular Cell, 
Hemmings and colleagues (Bozulic et al., 
2008) show that PKB is phosphorylated 
on both threonine 308 and serine 473 in 
response to either IR or the DNA-dam-
aging agent doxorubicin. Using selective 
kinase inhibitors, siRNA targeting, and 
PIKK-defective cell lines, the authors 
show that DNA-PKcs is required for the 
phosphorylation and activation of PKB 
in response to DNA damage. This newly 
identified pathway for IR-induced phos-
phorylation and activation of PKB is dis-
tinct from insulin-mediated activation of 
PKB, since inactivation of DNA-PK only 
disrupts activation of PKB in response 
to DNA-damaging agents. In addition, 
the authors show that PKB interacts with 
DNA-PKcs in an IR-inducible, phospho-
rylation-dependent manner. Not only do 
these studies reveal a new potential role 
for PKB in the DNA damage response 
but they also identify PKB as a new tar-
get for DNA-PKcs.
Given the traditional view of PKB-
mediated signaling that originates from 
the plasma membrane, a question that 
immediately comes to mind is where in 
the cell this pathway occurs. It turns out 
that PKB as well as its activating kinases 
(PI3K and PDK1) and their phospho-
inositide substrates are known to occur Cancein the nucleus as well as at the plasma 
membrane (reviewed in Deleris et al., 
2006). Here, Hemmings and colleagues 
demonstrate that DNA-PK-dependent, 
IR-induced phosphorylation of PKB 
occurs in the nucleus and that phos-
phorylated PKB colocalizes (to some 
extent) with phosphorylated histone-
H2AX, which is widely regarded as a 
marker for IR-induced DSBs (Stucki and 
Jackson, 2006). Given these findings, it 
will be interesting to determine whether 
DNA damage has effects on other com-
ponents of the nuclear phosphoinositide 
signaling pathway.
Most cells express multiple isoforms of 
PKB, termed PKBα/AKT1, PKBβ/AKT2, 
and PKBγ/AKT3, which have overlapping 
but distinct phenotypes. Mice lacking 
one or even two of the PKB isoforms are 
viable, but disruption of all three genes is 
lethal (Dummler and Hemmings, 2007). 
Bozulic et al. suggest that PKBα is likely 
the major player in IR-induced cell death, 
as cells from PKBα null animals undergo 
IR-induced apoptosis and deletion of 
PKBα reduces the presence of nuclear 
phospho-PKB foci. It will therefore be 
interesting to examine more closely the 
phenotype of PKBα null cells to deter-
mine whether they display other defects 
characteristic of NHEJ-defective cells, 
and to determine whether absence of 
PKBα causes defects in the repair of IR-
induced DSBs.
The authors also find that PKBα is 
required for upregulation of the cycle-
dependent kinase inhibitor p21 and sug-r Cell 13, May 2008 ©2008 Elsevier Inc. 379
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process. This is unexpected, since cell 
cycle regulation in response to IR has 
long been considered the function of 
the related PIKKs, Ataxia-Telangiectasia 
Figure 1. Activation of PKB/Akt in  
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(ATR) (Lobrich and Jeggo, 2007). More 
work will be required before we under-
stand precisely how DNA-PKcs and PKB 
are involved in this process.
In summary, the findings presented 
by Bozulic et al. suggest the following 
model (Figure 1). DNA damage induces 
DSBs (indicated by broken solid lines), 
which are detected by the Ku70/80 het-
erodimer. DNA-PKcs is recruited to the 
DSB via its interaction with Ku, which 
stimulates the protein kinase activity of 
DNA-PKcs, promoting the interaction 
of DNA-PKcs with nuclear PKB. Activa-
tion of DNA-PK results in phosphoryla-
tion of PKB on threonine 308 and serine 
473 (indicated by P in yellow circles) and 
activation of PKB, which, in turn phos-
phorylates downstream targets, which 
results in survival after IR. Whether DNA-
PKcs directly phosphorylates PKB or 
acts through PDK1 is not clear, since the 
authors also show that PDK1 has a role 
in the phosphorylation and activation of 
PKB in response to IR. Also, whether 
the interaction between DNA-PKcs and 
PKB is direct or indirect and whether it 
requires the phosphorylation of DNA-
PKcs and/or PKB is not yet known. Once 
activated, PKB induces the upregulation 
of the cyclin-dependent kinase inhibitor 
p21, which induces cell-cycle arrest and 
promotes cellular survival. Whether this er Inc.occurs through known PKB/AKT path-
ways that negatively regulate apoptosis, 
such as phosphorylation and negative 
regulation of proapoptotic proteins (such 
as BAD) or phosphorylation and regula-
tion of the activity of transcription factors 
(such as FOXO) (see Manning and Cant-
ley, 2007) or by other, yet to be discov-
ered, means remains to be determined.
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